Sponsored by Veradigm
Real world data (RWD) are being used by an increasingly diverse group of stakeholders. As an example, patient advocacy groups are realizing the value they can offer to their communities by partnering with data analysis companies to explore treatment pathways, health outcomes, and patient-reported measures of disease and treatment impact. And as we know, the life sciences industry and payers are using real world evidence (RWE) to look at diagnostic approaches, unmet needs, and gaps in treatment.
This blog reports practical uses of RWD sourced from the largest, cloud-based electronic health record (EHR) platform in the United States, offered by Veradigm® as part of its Health Insights database. Preliminary data were first obtained using a cost-effective software-as-a-service application that enables transparent and efficient analysis of RWD. Information technology and data visualization tools were then used to evaluate unstructured data to identify care gaps and inform diagnosis and management of patients with osteoporosis or osteopenia who are at risk for bone fracture. The complete research approach is described in a White Paper, available for download.
To read the full blog post on tHEORetically Speaking, the official blog of HealthEconomics.Com, click here.